Authors:
BONER G
VANDYK DJ
TAN MH
TAN J
EKSTRAND A
KOIVISTO VA
GROOP LC
GROOP PH
LUCAS A
ROMERO R
SALINAS I
SANMARTI A
ESCOBAR F
ESCOBARJIMENEZ F
CAMPOSPASTOR MM
MUGOZ M
GOMEZ M
MANGILI R
POZZA G
SPOTTI D
HANSEN KW
CHRISTIANSEN JS
KLEIN F
MOGENSEN CE
ZIEKENHUIS M
VANDOORN LG
SPOOREN PFMJ
CRUICKSHANK JK
JERVELL J
PAUS PN
BARNES DJ
COLLINS A
VIBERTI GC
WILLIAMS G
NELSTROP GA
AMOROSA L
ANOLIK JR
ARONOFF SL
EUBANK B
BAILIE M
PELLETIER L
BLEVINS T
CHARLES MA
PERRY M
CLARKE D
TOMKEY D
EINHORN D
HUMPHRIES D
GARBER AJ
HAAG B
WILLIAMS E
HOY W
WATKINS M
KAHKONEN D
KRUGER D
KILO C
LAFFEL L
GOLDEN E
LODEWICK P
LOVINSKY D
MASON J
JOHNSON S
MCGILL J
SCHMIDT L
ORLANDER P
SORENSON K
RASKIN P
HELLENBRAND D
ROSENBLATT S
SCHWARTZ S
AUFIERI J
SHEEHAN JP
ULCHAKER M
SKYLER JS
AGRAMONTE R
STARR J
GAGLIASTRE D
TAYLOR T
DAWN K
WARD WK
RIGDON M
COOPER M
GANS DJ
Citation: G. Boner et al., CAPTOPRIL REDUCES THE RISK OF NEPHROPATHY IN IDDM PATIENTS WITH MICROALBUMINURIA, Diabetologia, 39(5), 1996, pp. 587-593
Citation: Lmb. Laffel et al., THE BENEFICIAL EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH CAPTOPRIL ON DIABETIC NEPHROPATHY IN NORMOTENSIVE IDDM PATIENTS WITHMICROALBUMINURIA, The American journal of medicine, 99(5), 1995, pp. 497-504
Citation: Gc. Viberti et al., SECONDARY PREVENTION OF DIABETIC NEPHROPATHY BY CAPTOPRIL IN PATIENTSWITH INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) AND MICROALBUMINURIA, Journal of the American Society of Nephrology, 5(3), 1994, pp. 385-385
Citation: Jw. Mcfarland et Dj. Gans, ON IDENTIFYING LIKELY DETERMINANTS OF BIOLOGICAL-ACTIVITY IN HIGH-DIMENSIONAL QSAR PROBLEMS, Quantitative structure-activity relationships, 13(1), 1994, pp. 11-17